首页> 外文期刊>Journal of Sustainable Development >Study on the Treatment Process of Wastewater from Cephalosporin Production
【24h】

Study on the Treatment Process of Wastewater from Cephalosporin Production

机译:头孢菌素生产废水处理工艺研究

获取原文
       

摘要

Wastewater from cephalosporin production with high bio-toxicity is hard to degrade, and could cause great harm to environment and human being. In the present paper, wastewater from cephalosporin production was processed with biochemical treatments as follows: hydrolytic acidification- Up-flow Anaerobic Sludge Bed(UASB)-Sequencing Batch Reactor Activated Sludge Process(SBR)-biological activated carbon process(BAC). Among them, hydrolytic acidification could efficaciously enhance the biodegradability of wastewater, and greatly increase effects of the subsequent anaerobic-aerobic treatment. The final BAC process could effectively eliminate chemical oxygen demand (COD) and chroma of wastewater treated by aerobic treatment, where COD attained below 100mg/L and chroma was 40. Therefore, wastewater after the previous treatments basically conformed to the discharge standard of " Integrated wastewater discharge standard "(GB8978-1996).
机译:具有高生物毒性的头孢菌素生产产生的废水难以降解,并且可能对环境和人类造成极大伤害。本文对头孢菌素生产废水进行了生化处理,工艺流程为:水解酸化-上流厌氧污泥床(UASB)-测序间歇反应器活性污泥法(SBR)-生物活性炭法(BAC)。其中,水解酸化可有效提高废水的生物降解性,并大大提高后续厌氧-好氧处理的效果。 BAC的最终工艺可以有效消除需氧处理废水的化学需氧量和色度,其中COD低于100mg / L,色度为40。因此,经过前处理的废水基本符合《综合排放标准》的排放标准。废水排放标准》(GB8978-1996)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号